Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares Outstanding
Ratios

Mesa Laboratories (MLAB) Shares Outstanding (2016 - 2025)

Mesa Laboratories' Shares Outstanding history spans 15 years, with the latest figure at $5.5 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1.68% to $5.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 million, a 1.68% increase, with the full-year FY2025 number at $5.5 million, up 1.13% from a year prior.
  • Shares Outstanding hit $5.5 million in Q4 2025 for Mesa Laboratories, roughly flat from $5.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding for MLAB hit a ceiling of $5.5 million in Q4 2025 and a floor of $5.1 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $5.4 million across 5 years, with a median of $5.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding: grew 17.17% in 2021 and later increased 0.46% in 2024.
  • Tracing MLAB's Shares Outstanding over 5 years: stood at $5.2 million in 2021, then grew by 1.85% to $5.3 million in 2022, then grew by 0.98% to $5.4 million in 2023, then increased by 0.73% to $5.4 million in 2024, then grew by 1.68% to $5.5 million in 2025.
  • Business Quant data shows Shares Outstanding for MLAB at $5.5 million in Q4 2025, $5.5 million in Q3 2025, and $5.5 million in Q2 2025.